6 completed. 4 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow N-phenylacetoaminomethylene-DL-p-nitrophenylalanine: new trials by email Literature Review of N-phenylacetoaminomethylene-DL-p-nitrophenylalanine trials Research Report on N-phenylacetoaminomethylene-DL-p-nitrophenylalanine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of A-101 Topical Solution for the Treatment of Common Warts A-101 - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 426 | 2019-02-07 | 2020-11-23 |
| Study of A-101 Topical Solution for the Treatment of Common Warts A-101, vehicle - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 503 | 2018-09-17 | 2020-10-05 |
| A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis A-101 - Seborrheic Keratosis | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 253 | 2017-05-17 | 2019-05-06 |
| Study of A-101 for the Treatment of Seborrheic Keratosis A-101 - Seborrheic Keratosis | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 119 | 2014-10-01 | 2020-12-02 |
| Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis A-101 Vehicle, A-101 (40) Topical Solution, A-101 (32.5) Topical Solution - Seborrheic Keratosis | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 172 | 2014-06-01 | 2019-01-03 |
| Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis A-101 25%, A-101 32.5%, A-101 40% - Seborrheic Keratosis (SK) | Phase 1 / Phase 2 | Completed | Aclaris Therapeutics, Inc. | 35 | 2013-10-22 | 2018-12-11 |
Keratosis, Seborrheic (4) · Warts (2)
Aclaris Therapeutics, Inc. (6)
United States (6)
Janet Dubois, MD (2) · Andrew Blauvelt, MD, MBA (1) · Brian Beger, BS (1) · Daniel M Stewart, DO (1) · David C Wilson, MD (1) · David Gordon, MB, ChB (1) · Jonathan S Weiss, MD (1) · Stuart D Shanler, MD (1)